Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gail Darling

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Oncotarget|April 22, 2017
Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcomeGrzegorz J Korpanty, Lawson Eng, Xin Qiu, et al.
Oncotarget|March 31, 2016
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancerAdrian G Sacher, Lisa W Le, Humberto Lara-Guerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Three-gene prognostic classifier for early-stage non small-cell lung cancerSuzanne K Lau, Paul C Boutros, Melania Pintilie, et al.
Cancer Medicine|February 13, 2014
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancersKit Man Wong, Xiaoping Qiu, Dangxiao Cheng, et al.
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guidelineKatherine M W Pisters, William K Evans, Christopher G Azzoli, et al.
Lancet (London, England)|July 28, 2009
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialKathy S Albain, R Suzanne Swann, Valerie W Rusch, et al.
The Lancet. Respiratory Medicine|November 17, 2018
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)Nasser K Altorki, Xiaofei Wang, Dennis Wigle, et al.
Oncology|October 14, 2020
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction CancerDi Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, et al.
Annals of Surgery|December 6, 2017
Benchmarking Complications Associated with EsophagectomyDonald E Low, Madhan Kumar Kuppusamy, Derek Alderson, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Oncotarget|April 22, 2017
Association of BRM promoter polymorphisms and esophageal adenocarcinoma outcomeGrzegorz J Korpanty, Lawson Eng, Xin Qiu, et al.
Oncotarget|March 31, 2016
A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancerAdrian G Sacher, Lisa W Le, Humberto Lara-Guerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Three-gene prognostic classifier for early-stage non small-cell lung cancerSuzanne K Lau, Paul C Boutros, Melania Pintilie, et al.
Cancer Medicine|February 13, 2014
Two BRM promoter insertion polymorphisms increase the risk of early-stage upper aerodigestive tract cancersKit Man Wong, Xiaoping Qiu, Dangxiao Cheng, et al.
The New England Journal of Medicine|September 16, 2024
Preoperative Chemoradiotherapy for Resectable Gastric CancerTrevor Leong, B Mark Smithers, Michael Michael, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guidelineKatherine M W Pisters, William K Evans, Christopher G Azzoli, et al.
Lancet (London, England)|July 28, 2009
Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialKathy S Albain, R Suzanne Swann, Valerie W Rusch, et al.
The Lancet. Respiratory Medicine|November 17, 2018
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503)Nasser K Altorki, Xiaofei Wang, Dennis Wigle, et al.
Oncology|October 14, 2020
Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction CancerDi Maria Jiang, Hao-Wen Sim, Osvaldo Espin-Garcia, et al.
Annals of Surgery|December 6, 2017
Benchmarking Complications Associated with EsophagectomyDonald E Low, Madhan Kumar Kuppusamy, Derek Alderson, et al.
Pageof 13